Zollinger-Ellison syndrome, acromegaly, and colorectal neoplasia

Journal of Clinical Gastroenterology

Volumn 24, Issue 1, 1997, Pages 21-24

  Tobi, Martin ^a,d   Cats, Annemieke ^b   Maliakkal, Benedict J ^a   Kinzie, Joseph L ^a   Maliakkal, Roy ^a   Dullaart, Robin P F ^b   Luk, Gordon D ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Colorectal cancer; Hypergastrinemia

Indexed keywords

CANCER ANTIBODY; TUMOR MARKER;

ACROMEGALY; ADULT; AGED; ARTICLE; CANCER RISK; CASE REPORT; COLORECTAL TUMOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; MALE; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

ACROMEGALY; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; ZOLLINGER-ELLISON SYNDROME;

EID: 0031029614     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199701000-00004     Document Type: Article

References (42)

1. Wormsley KG. Is hypergastrinemia dangerous for man? Scand J Gastroenterol 1991;26:174-8.
2. Creutzfeldt W, Lamperts R. Is hypergastrinemia dangerous to man? Scand J Gastroenterol 1991;26:179-91.
3. Morris DL, Watson SA, Durrant LG, Harrison JD. Hormonal control of gastric and colorectal cancer in man. Gut 1989;30: 4254-9.
4. Pinson DM, Havu N, Sztern MI, et al. Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats. Gastroenterology 1995;108:1068-74.
5. Rehfield JF. Gastrin and colorectal cancer: a never-ending dispute? Gastroenterology 1995;108:1307-10.
6. Tobi M, Maliakkal B, Chintalapani S, Luk G. Remodeling the hypergastrinemia model. Gastroenterology 1995;109:1407.
7. Chu M, Nielsen FC, Franzen L, Rehfield JF, Holst JJ, Borch K. Effect of endogenous hypergastrinemia on gastrin receptor expressing human colon carcinoma transplanted to athymic rats. Gastroenterology 1995;109:1415-20.
8. Smith JP, Wood JG, Solomon TE. Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci 1989;34:171-4.
9. Elsborg L, Mosbach J. Pernicious anemia as a risk factor in gastric cancer. Acta Med Scand 1979;206:315-8.
10. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ III. Risk for colorectal adenocarcinoma in pernicious anemia: a population-based cohort study. Ann Intern Med 1989;111:738-42.
11. Brinton LA, Gridley G, Hrubec Z, Hoover R, Fraumeni JF Jr. Cancer risk following pernicious anaemia. Br J Cancer 1989;59:810-3.
12. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonie mucosa. Gastroenterology 1993;105:22-30.
13. Tobi M, Mehta R, Nunez J, et al. Zollinger-Ellison syndrome, hypergastrinemia and colorectal neoplasia [Abstract]. Gastroenterology 1990;98:A315.
14. Delcore R, Friesen SR. Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome. Surgery 1992;112:1016-23.
15. Tobi M, Hassan N, Memon N, et al. Zollinger-Ellison syndrome (ZES), acromegaly and colorectal neoplasia: increased expression of a preneoplastic marker [Abstract]. Proc Am Assoc Cancer Res 1993;34:241.
16. Klein I, Parveen G, Gavaler JS, Van Thiel DH. Colonie polyps in patients with acromegaly. Ann Intern Med 1982;97:27-30.
17. Pines A, Rozen P, Ron E, Gilat T. Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 1985;80:266-9.
18. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC. Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol 1990;32:65-71.
19. Ezzat S, Strom C, Melmed S. Colon polyps in acromegaly. Ann Intern Med 1991;114:754-5.
20. Tobi M, Darmon E, Phillips T, et al. Increased expression of a putative adenoma associated antigen in precolonoscopic effluent of patients with colorectal cancer. Cancer Lett 1990;50:21-5.
21. Tobi M, Kaila V, Goo R, et al. An adenoma-associated antigen as a preneoplastic marker in familial polyposis coli versus sporadic colonie neoplasia [Abstract]. Gastroenterology 1992; 102:A403.
22. Tobi M, Maliakkal B, Alousi MA, et al. Cellular distribution of a colonie adenoma-associated antigen as defined by monoclonal antibody Adnab-9. Scand J Gastroenterol 1992;27:737-42.
23. Tobi M, Elitsur Y, Moyer MP, et al. Mucosal origin and shedding of an early colonic tumor marker defined by Adnab-9 monoclonal antibody. Scand J Gastroenterol 1993;28:1025-34.
24. Lowry OH, Rosenbrough NJ, Fair AL, Randall RJ. Protein measurements with folin phenol reagents. J Biol Chem 1951; 193:265-75.
25. Orbuch M, Lubensky IA, Weber HC, Strader DB, Gibril F, Jensen RT. Prolonged, marked hypergastrinemia does not increase the rate of colonic neoplasia [Abstract]. Gastroenterology 1994;106:A152.
26. Boland CR. Malignant tumors of the colon. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of gastroenterology, vol. 2. Philadelphia: Lippincott, 1991:1768-813.
27. Delendi M, Gardiman D, Riboli E, Sasco AT. Latent colorectal cancer found at necropsy. Lancet 1989;1:1331-2.
28. Eisen GM, Sandler RS, Wurzelmann JI, Ransohoff DF, Talal A. Evaluating risk: a primer for gastroenterologists. Am J Gastroenterol 1995;90:704-7.
29. Rozen P, Fireman Z, Figer A, Legum C, Ron E, Lynch HT. Family history of colorectal cancer as a marker of potential malignancy within a screening program. Cancer 1987;60: 248-54.
30. Guillem JG, Forde KA, Treat MR, Neugut AI, O'Toole KM, Diamond BE. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. Dis Col Rectum 1992;35:523-9.
31. Prager ED, Swinton NW, Young JL, Veindenheimer MC, Corman ML. Follow-up study of patients with benign mucosal polyps discovered by proctosigmoidoscopy. Dis Col Rectum 1974;17:322-4.
32. McGuigan JE. The Zollinger-Ellison syndrome. In: Sleisinger MF, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 4th ed. Philadelphia: Saunders, 1989:909-25.
33. Del Valle J, Yamada T. Zollinger-Ellison syndrome. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE, eds. Textbook of gastroenterology, vol. 1. Philadelphia: Lippincott, 1991:1340-52.
34. Solcia E, Capella C, Fiocca R, Cornaggia M, Bosi F. The gastroentero-pancreatic endocrine system and related tumors. Gastroenterol Clin North Am 1989;18:671-4.
35. Stockbrugger RW, Menon CG, Beilby JOW, Mason RR, Cotton PB. Gastroscopic screening in 80 patients with pernicious anemia. Gut 1983;24:1141-7.
36. Borch K, Renvall H, Ledberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985;88:638-48.
37. Lehtola J, Karttunen T, Krekela I, Niemala S, Rasanen O. Gastric carcinoids with minimal or no macroscopic lesion in patients with pernicious anemia. Hepatogastroenterology 1985; 32:72-6.
38. Cats A, Dullart RPF, Zwart N, Kleibeuker JH, de Vries EGE. Increased colonie epithelial cell proliferation in acromegalic patients [Abstract]. Proc Am Assoc Cancer Res 1993;34:1142.
39. Murphy J, Schaaf M, Luk G, et al. Mucosal proliferation is increased in patients with active acromegaly [Abstract]. Gastroenterology 1993;104:A433.
40. Ciccotosto GD, McLeish A, Hardy KT, Shulkes A. Expression processing and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995;109:1142-53.
41. Cats A, Kleibeuker JH, Chintalapani S, Tobi M. A premalignant marker for adenoma carcinoma carcinogenesis shows increased expression in hereditary non-polyposis colon cancer (HNPCC) patients [Abstract]. Gastroenterology 1994;106:A376.
42. Jensen RT, Gardner JD. Zollinger-Ellison syndrome: clinical presentation, pathology, diagnosis, and treatment. In: Zakim D, Dannenberg AJ, eds. Peptic ulcer disease and other acid-related disorders. New York: Academic Research, 1991:1187-211.